Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MAPKAPK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC5A6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBM15B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC39A8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
XXYLT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM183B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NME4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD48 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HSD17B12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HMGCR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNPEP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TCTN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYP2C9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BAG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STOML2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC33A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPRD1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRP6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL23 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on